David Baker on AI, open science, and building biotech startups

Our director David Baker recently shared his thoughts on the impact of AI on life sciences and healthcare startups. He spoke with Jenny Cronin, principal at the Allen Institute for AI (AI2) Incubator.

This post highlights key points from the discussion, which was part of START SOMETHING, a series by UW CoMotion that features conversations with entrepreneurs and innovators. The full conversation is available on YouTube.

Integrating AI into Protein Science

“We have a lot of people wanting to collaborate and visit, and they often bring in ideas.”

The Institute for Protein Design is at the center of a technological revolution. For decades, David’s group and others developed and used traditional physics-based software such as Rosetta to model and design biomolecules. Today, AI-driven approaches, notably deep learning, are transforming this work. 

AI tools for protein design have enhanced our ability to create molecules with advanced functions, including experimental vaccines, medicines, nanomaterials, and much more. Many of the most powerful and popular AI-based tools for protein science were created here at the Institute for Protein Design.

AI’s Impact on Therapeutics and Beyond

“I think we’re going to see a transition from protein therapeutics being obtained by kind of black magic — immunizing an animal and letting the natural immune system come up with a solution — to actually being designed rationally.”

Beyond using protein design to create medicines, David spoke about work happening here in non-therapeutic areas, including artificial photosynthetic systems and nanopore design for diagnostics. 

The Power of Open Science

“In our space, making code freely available has been clearly the best thing.”

We have elected to make all of our most powerful AI-driven tools for protein design, including RFdiffusion and ProteinMPNN, completely open source, meaning any researcher in the world can use them or improve on them at no cost. David discussed how this strategy has allowed for much greater collaboration and innovation, leading to a worldwide explosion in new protein design technologies and applications.

David’s advice for budding scientists and entrepreneurs: be open to collaborations and reach out to experts in your field.

“I encourage my students to just email people. If they’re working on a problem, I say figure out who the best three people are in the world and email them. Sometimes you won’t get an answer, but other times you will, and that can start a connection which could really transform your research.”

The Commercial Potential of Scientific Research

“If you choose the right problems, where this is the time to solve them, a surprisingly large fraction will have some commercial potential — maybe in a way that you didn’t anticipate. That certainly happened with a lot of the things we’ve done.”

Our Institute fosters entrepreneurship in many ways, including through our Translational Investigator Program and by encouraging open dialogue among researchers within and beyond our walls.

Seattle as a Biotech Hub

David’s commitment to his hometown, Seattle, has contributed to the city becoming a thriving ecosystem for biotech startups. Many of our Institute’s spinouts were formed and remain in Seattle, which has been pivotal in building this ecosystem. We look forward to launching many more companies in this vibrant city.

“If you want to hire people who know how to do protein design, Seattle is definitely the best place.”

Share via
Copy link